Lamotrigine

References

• Timmings PL, Richens A. Lamotrigine in primary generalised epilepsy. Lancet 339, 1300–1301 (1992).
   PubMed Web of Science ®Google Scholar
• Sander BA/AS, Patsalos PN. An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotriginetherapy. Epilepsy Res. 13, 89–92 (1992).
   PubMed Web of Science ®Google Scholar
• Cunningham MO, Jones RS. The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increased spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology 39, 2139–2146 (2000).
   PubMed Web of Science ®Google Scholar
• Eriksson A-S, Knutsson E, Nergardh A. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy. Epilepsia 42, 230–236 (2001).
   PubMedGoogle Scholar
• Goa KL, Ross SR, Chrisp P. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46, 152–176 (1993).
   Google Scholar
• Cohen AF, Land S, Breimer DD et al. Lamotrigine, a new anticonvulsant: Pharmacokinetics in norman humans. Clin. Pharmacol. Ther. 42, 535–541 (1987).
   PubMed Web of Science ®Google Scholar
• Miller AA, Wheatley P, Sawyer DA et al. Pharmacological studies on lamotrigine, a novel antiepileptic drug: I. Anticonvulsant profiles in mice and rats. Epilepsia 27, 483–489 (1986).
   PubMed Web of Science ®Google Scholar
• Ebert U, Thong NQ, Oertel R, Kirch W Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects. Eur. Clin. Pharmacol. 56, 299–304 (2000).
   Web of Science ®Google Scholar
• Binnie CD, Debets RM, Engelsman M et al. Double-blind crossover trial of lamotrigine (Lamicta0 as add-on therapy in intractable epilepsy. Epilepsy Res. 4, 222–229 (1989).
   PubMed Web of Science ®Google Scholar
• Yuen AWC, Land G, Weatherley BC, Peck AW. Sodium valproate acutely inhibits lamotrigine metabolism. Br. j Clin. Pharmacol. 33, 511–513 (1992).
   PubMed Web of Science ®Google Scholar
• Willmore U. The effect of age on pharmacokinetics of antiepileptic drugs. Epilepsia 36, 15–21 (1995).
   Web of Science ®Google Scholar
• Willmore U. Choice and use of newer anticonvulsant drugs in older patients. Drugs Aging 17, 441–452 (2000).
   PubMed Web of Science ®Google Scholar
• Willmore LJ, Messenheimer JA. Adult experience with lamotrigine. J. Child Neurol. 12, S16—S18 (1997).
   Web of Science ®Google Scholar
• Panayiotopoulos CP, Ferrie CD, Knott C et al. Interaction of lamotrigine with sodium valproate. Lancet 341, 445 (1993).
   PubMed Web of Science ®Google Scholar
• Morris RG, Black AB, Lam E, Westley IS. Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage? Ther. Drug Monit. 22, 656–660 (2000).
   PubMed Web of Science ®Google Scholar
• Wootton R, Soul-Lawton J, Rolan PE, Fook Sheung CTC, Cooper JDH, Posner J. Comparison of the pharmacokinetics of lamotrigine in patients with chronic reanl failure and healthy volunteers. Br. j Clin. Pharmacol. 43, 23–27 (1997).
   PubMed Web of Science ®Google Scholar
• Battino D, Croci D, Granata T, Mamoli A, Messina S, Perucca E. Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedication. Ther. Drug Monit. 23, 217–222 (2001).
   PubMed Web of Science ®Google Scholar
• Chen C, Casale EJ, Duncan B, Culverhouse EH, Gilman J. Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs. Pharmacotherapy 19, 437–441 (1999).
   Google Scholar
• Messenheimer JA. Lamotrigine. Epilepsia 36\(Suppl. 2), S87—S94 (1995).
   Google Scholar
• Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of Lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 30, 356–363 (1989).
   PubMed Web of Science ®Google Scholar
• Loiseau P, Yuen AWC, Duche B, Menager T, Arne-Bes MC. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res. 7, 136–145 (1990).
   Google Scholar
• Sander J, Patsalos P, Oxley J, Hamilton M, Yuen WA. A randomized, double-blind, placebo-controlled, add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res. 6, 221–226 (1990).
   Google Scholar
• Matsuo F, Bergen D, Faught E et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurol 43, 2284–2291 (1993).
   PubMed Web of Science ®Google Scholar
• Schapel GJ, Beran RG, Vajda FJE et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment resistant partial seizures. j NeuroL Neurosurg. Psychiatry56, 448–453 (1993).
   PubMed Web of Science ®Google Scholar
• Messenheimer JA, Ramsay RA, Willmore LJ et al. Lamotrigine therapy for partial seizures: a multicenter placebo-controlled, double-blind, crossover trial. Epilepsia 35, 113–121 (1994).
   PubMed Web of Science ®Google Scholar
• Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcome of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 34, 312–322 (1993).
   PubMed Web of Science ®Google Scholar
• Richens A, Yuen AWC. Overview of the clinical efficacy of lamotrigine. Epilepsia 32\(Suppl. 2), S13—S16 (1992).
   Google Scholar
• Faugh ER, Leroy RE Messenheimer JA et al. Clinical experience with lamogrigine (Lamictal) monotherapy for partial seizures in adult out-patients. Epilepsia 33\(Suppl. 3), 82 (1992).
   Google Scholar
• Steiner TJ, Silviera C, Yuen AWC. Comparisone of lamotrigine (Lamictal) and phenytoin monotherapy in newly diagnosed epilepsy. Epilepsia 35\(Suppl. 7), 61 (1994).
   Google Scholar
• Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 345, 476–479 (1995).
   Google Scholar
• Brodie MJ, Richens A, UK Lamotriginel Carbamazepine Monotherapy Trial Group. Lamotrigine versus carbamazepine: a double-blind comparative study in newly diagnosed epilepsy. Epilepsia 35\(Suppl. 8), 31 (1994).
   Google Scholar
• Chapman A, Yuen MC. Lamotrigine (Lamictal) versus carbamazepine as monotherapy in patients with epilepsy. Epilepsia 35, 69 (1994).
   Google Scholar
• Gilliam F, Vasquez B, Sackellares JC et al An active-control trial of lamotrigine monotherapy for partial seizures. NeuroL 51, 1018–1025 (1998).
   PubMed Web of Science ®Google Scholar
• Binnie CD. Efficacy of lamotrigine in add- on controlled studies. In: Reynolds EH (ed). Lamotrigine-a new advance in the treatment of epilepsy Royal Society Medicine London, UK pp 25–34 (1993).
   Google Scholar
• Peck AW Lamotrigine: historical background. Rev Contemp. Pharmacother. 5, 95–105 (1994).
   Google Scholar
• Messenheimer JA, Mullens EJ, Giorgi L, Young E Safety review of adult clinical trial experience with lamotrigine. Drug Sal: 18, 281–296 (1998).
   PubMed Web of Science ®Google Scholar
• Messenheimer JA, Giorgi L, Risner ME. The tolerability of lamotrigine in children. Drug Sal: 22, 303–312 (2000).
   PubMed Web of Science ®Google Scholar
• Kluger G. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy. Eur j Paediatr. Neurol 5, 37–40 (2001).
   PubMedGoogle Scholar
• Parmeggiani L, Belmonte A, Ferrari AR, Perucca E, Guerrini R. Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: an open, prospective long-term study. j Child NeuroL 15, 671–674 (2000).
   PubMed Web of Science ®Google Scholar
• Duchowny M, Pellock JM, Graf WD eta] A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. NeuroL 53, 1724–1731 (1999).
   Google Scholar
• Barron TF, Hunt SL, Hoban TF, Price ML. Lamotrigine monotherapy in children. Pediatr. NeuroL 23, 160–163 (2000).
   PubMed Web of Science ®Google Scholar
• Motte J, Trevathan E, Arvidsson JFV et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl. Med. 337, 1807–1812 (1994).
   Google Scholar
• Donaldson JA, Glauser TA, Olberding LS. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome). Epilepsia 38, 68–73 (1997).
   PubMed Web of Science ®Google Scholar
• Timmings PL, Richens A. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome. Eur. Neurol 32, 305–307 (1992).
   PubMed Web of Science ®Google Scholar
• Eriksson AS, Nergardh A, Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia 39, 495–501 (1998).
   PubMed Web of Science ®Google Scholar
• Guerrini R, Dravet C, Genton P et aL Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39, 508–512 (1998).
   PubMed Web of Science ®Google Scholar
• Proceedings: of the Peripheral and Central Nervous System Drugs Advisory Committee Meeting #36. Lamictal (Lamotrigine). Proceedings 1993, March 20, (1993).
   Google Scholar
• Schlienger RG, Shapiro LE, Shear NH. Lamotrigine-induced severe cutaneous adverse reactions. Epilepsia 39, S22—S26 (1998).
   Google Scholar
• Page RL, O'Neil MG, Yarbrough DR, Conradi S. Fatal toxic epidermal necrolysis related to lamotrigine administration. Pharmacotherapy 18, 392–398 (1998).
   PubMed Web of Science ®Google Scholar
• Yalcin B, Karaduman A. Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid. Am. Acad. Dermatol 43, 898–899 (2000).
   PubMed Web of Science ®Google Scholar
• Pellock JM, Brodie MJ. Felbamate: 1997 update. Epilepsia 38, 1261–1264 (1997).
   PubMed Web of Science ®Google Scholar
• Wong ICK, Mawer GE, Sander JVVAS. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom. Epilepsia 42, 237–244 (2001).
   PubMed Web of Science ®Google Scholar
• Mackay FJ, Wilton LV, Pearce GL, Freemantle SN. Safety of long-term lamotrigine in epilepsy. Epilepsia 38, 881–886 (1997).
   PubMed Web of Science ®Google Scholar
• Guberman AH, Besag FMC, Brodie MJ et al. Lamotrigine-associated rash: Risk/ benefit consideratins in adults and children. Epilepsia 40, 985–991 (1999).
   PubMed Web of Science ®Google Scholar
• Brown TS, Appel JE, Kasteler JS, Callen JP Hypersensitivity reaction in a child due to lamotrigine. Pediatr. DermatoL 16, 46–49 (1999).
   PubMed Web of Science ®Google Scholar
• Schlienger RG, Knowles SR, Shear NH. Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurol 51, 1172–1175 (1998).
   Google Scholar
• Schaub N, Bircher AJ. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy55, 191–193 (2000).
   PubMed Web of Science ®Google Scholar
• Maggs JL, Naisbitt DJ, Tettey JN, Pirmohamed M, Park BK. Metabolism of lamotrigine to a reactive arene oxide intermediate. Chem. Res. ToxicoL 13, 1075–1081 (2000).
   Google Scholar
• Iannetti P, Raucci U, Zuccaro P, Pacifici R. Lamotrigine hypersensitivity in childhood epilepsy. Epilepsia 39, 502–507 (1998).
   PubMed Web of Science ®Google Scholar
• Beran RG, Gibson RJ. Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 39, 280–282 (1998).
   PubMed Web of Science ®Google Scholar
• Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurol 56,172–177 (2001).
   PubMed Web of Science ®Google Scholar
• Anonymous. Lamotrigine associated with insomnia. Epilepsia 41,920–921 (2000).
   Google Scholar
• O'Donnell J, Bateman DN. Lamotrigine overdose in an adult. j Toxic& Clin. Toxic& 38,659–660 (2000).
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Kalabalikis P, Tamiolaki M, Hatzis T. Lamotrigine childhood overdose. Pediatr. Neurol 19,239–243 (1998).
   PubMed Web of Science ®Google Scholar
• Makin AJ, Fitt S, Williams R, Duncan JS. Fulminant hepatic failure induced by lamotrigine. BMJ311,292 (1995).
   PubMedGoogle Scholar
• Arnon R, De Vivo D, Defelice AR, Kazlow PG. Acute hepatic failure in a child treated with lamotrigine. Pediatr. Neurol 18(3), 251–252 (1998).
   PubMed Web of Science ®Google Scholar
• Sarris BM, Wong JG. Multisystem hypersensitivity reaction to lamotrigine. Neurol 53,1367 (1999).
   PubMed Web of Science ®Google Scholar
• Schaub JE, Williams PJ, Barnes EW, Trewby PN. Multisystem adverse reaction to lamotrigine. Lancet 344,481 (1994).
   PubMed Web of Science ®Google Scholar
• Sauve G, Bresson-Hadni S, Prost P et al. Acute hepatitis after lamotrigine administration. Dig. Dis. Sci. 45,1874–1877 (2000).
   PubMed Web of Science ®Google Scholar
• de Camargo OA, Bode H. Agranulocytosis associated with lamotrigine. BMJ318, 1179 (1999).
   PubMedGoogle Scholar
• Pathak P, McLachlan RS. Drug-induced pseudolymphoma secondary to lamotrigine. Neurol 50,1509–1510 (1998).
   PubMed Web of Science ®Google Scholar
• Carrazana EJ, Wheeler SD. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurol 56,1424–1425 (2001).
   PubMed Web of Science ®Google Scholar
• Dravet C, Bureau M, Guerrini R, Giraud N, Roger J. Severe myoclonic epilepsy in infants. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P (eds). Epileptic syndromes in infancy childhood and adolescence. John Libbey, London, UK pp 75–88 (1992).
   Google Scholar
• Janszky J, Rasonyi G, Halasz P et al. Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases. Clin. Neuropharmacol 23,86-89o:00y
   Google Scholar
• Guerrini R, Belmonte A, Earmeggiani L, Perucca E. Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev. 21,420–424 (1999).
   PubMed Web of Science ®Google Scholar
• Conroy BP, Black D, Lin CY et al Lamotrigine attenuates cortical glutamate release during global cerebral ischaemia in pigs on cardiopulmonary bypass. Anesthesiology 90,844–854 (1999).
   PubMed Web of Science ®Google Scholar
• Anttila V, Rimpilainen J, Pokela M et al. Lamotrigine improves cerebral outcome after hypothermic circulatory arrest: a study in chronic porcine model. J. Thorac. Cardiovasc. Surg. 120,247–255 (2000).
   PubMed Web of Science ®Google Scholar
• Koinig H, Williams JP, Quast MJ, Zornow MH. Effect of neuronal sodium channel blocker on magnetic resonance derived indices of brain water content during global cerebral ischaemia. Brain Res. 887,301–308 (2000).
   PubMed Web of Science ®Google Scholar
• Lee YS, Yoon BW, Roh JK. Neuroprotective effects of lamotrigine enhanced by flunarizine in gerbil global ischaemia. Neurosci. Lett. 265,215–217 (1999).
   Google Scholar
• Lee WT, Shen YZ, Chang C. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Neuroscience 95,89–95 (2000).
   Google Scholar
• Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl. j Med. 323, 497–502 (1990).
   PubMed Web of Science ®Google Scholar
• Temkin NR, Dikmen SS, Anderson GD et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. Neurosurg. 91,593–600 (1999).
   Web of Science ®Google Scholar
• Postma T, Krupp E, Li X-L, Post RM, Weiss SRB. Lamotrigine treatment during amygdala-kindled sezizure development fails to inhibit seizures and diminishes subsequent anticonvuslant activity. Epilepsia 41,1514–1521 (2001).
   Google Scholar
• Panayiotopoulos CE Treatment of typical absence seizures and related epileptic syndromes. Paediatr. Drugs 3,379–404 (2001).
   Google Scholar
• Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CE Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand. 91,200–202 (1995).
   PubMed Web of Science ®Google Scholar
• Buoni S, Grosso S, Fois A. Lamotrigine in typical absence epilepsy. Brain Dev 21, 303–306 (1999).
   Google Scholar
• Frank LM, Enlow T, Holmes GL et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 40,973–979 (1999).
   PubMed Web of Science ®Google Scholar
• Arzimanoglou A, Kulak I, Bidaut-Mazel C, Baldy-Moulinier M. Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy. Rev Neurol Ads) 157,525–536 (2001).
   PubMed Web of Science ®Google Scholar
• Lhatoo SD, Wong IC, Polizzi G, Sander JVV. Long-term retention rates of lamotrigine, gabapentin and topiramate in chronic epilepsy. Epilepsia 41,1592–1596 (2000).
   PubMed Web of Science ®Google Scholar
• Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40,1141–1146 (2001).
   Web of Science ®Google Scholar
• Faught E, Morris G, Jacobson M et al. Adding lamotrigine to valproate: incidence of rash and other adverse effexts. Postmarketing Antiepileptic Drug Survey (PADS) Group. Epilepsia 40,1135–1140 (1999).
   Google Scholar
• Beran RG, Berkovic SF, Dunagan FM et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia 39, 1329–1333 (1998).
   PubMed Web of Science ®Google Scholar
• Farrell K, Connolly MB, Munn R, Peng S, MacWilliam LM. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. Pediatr. Neurol 16,201–205 (1997).
   Google Scholar
• Steiner TJ, Dellaportas CI, Findley LJ et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 40,601–607 (1999).
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Ray PG et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurol 56,1177-1182 moly
   Google Scholar
• Martin R, Kuzniecky R, Ho S et al. Cognitive effects of topiramate, gabapentin and lamotrigine in healthy young adults. Neurol 52,321–327 (2000).
   Web of Science ®Google Scholar
• Zeijav-Lacombe S, Tabarsi E. Lamotrigine: a review of clinical studies in bipolar disorders. Can. PTchiatry 46, 328–333 (2001).
   Google Scholar
• Bowden CL. Novel treatments for bipolar disorder. Expert Opin. Investig. Drugs 10, 661–671 (2001).
   PubMed Web of Science ®Google Scholar
• Ketter TA, Kimbrell TA, Dunn RT et al A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. .1. Clin. Psychopharmacol 20,607–614 (2000).
   Google Scholar
• Calabrese JR, Suppes T, Bowden CL eta]. A double-blind,placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. .1. Clin. Psychiatry 61,841–850 (2000).
   Google Scholar
• Hertzberg MA, Butterfield MI, Feldman ME et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol. Psychiatry 45, 1229 (1999).
   Web of Science ®Google Scholar
• Showalter PE, Kimmel DN. Stimulating consciousness and cognition following severe brain injury: a new potential clinical use for lamotrigine. Brain Inj 14,997–1001 (2000).
   PubMed Web of Science ®Google Scholar
• Margolin A, Avants SK, DePhilippis D, Kosten TR. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am. .1. Drug Alcohol Abuse 24,85–101 (1998).
   Google Scholar
• D'Andrea G, Granella F, Cadaldini M, Manzoni GC. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 19,64–66 (1999).
   PubMed Web of Science ®Google Scholar
• Lampl C, Buzath A, Klinger D, Neumann K. Lamotrigine in the prophylactic treatment of migraine aura-a pilot study. Cephalalgia 19,58–63 (1999).
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17, 109–112 (1997).
   Google Scholar
• Crawford P, Brown S, Kerr M. A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy. Seizure 10 107–115 (2001).
   Google Scholar
• Kumandas S, Caksen H, Ciftci A, Ozturk M, Per H. Lamotrigine in two cases of Rett syndrome. Brain Dev 23,240–242 (2001).
   Google Scholar
• Delvaux V, Schoenen J. New generation antiepileptics for facial pain and headache. Acta Neurol. Belgium 101,42–46 (2001).
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine Oamicta0 in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial. Pain 73,223–230 (1997).
   Google Scholar
• Simpson DM, Olney R McArthur JC, Kahn A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurol 54,2115–2119 (2000).
   Google Scholar
• Leone M, Rigamonti A, Usai S, DAmico D, Grazzi L, Bussone G. Two new SUNCT cases responsive to lamotrigine. Cephalalgia 20,845–847 (2000).
   PubMed Web of Science ®Google Scholar
• Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurol. 56,2–184 (2001).
   Web of Science ®Google Scholar
• Holmes LB, Harvey EA, Coull BA et al The teratogenicity of anticonvulsant drugs. N. Engl. Med 344,1132–1138 (2001).
   PubMed Web of Science ®Google Scholar
• Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am. J. Obstet. Gynecol. 182,159-163 (2000).
   Google Scholar
• Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate and during lactation. Epilepsia 41,709–713 (2000).
   PubMed Web of Science ®Google Scholar
• Tomson T, Ohman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 38,1039–1041 (1997).
   PubMed Web of Science ®Google Scholar
• Fervenza FC, Kanakiriya S, Kunau RT, Gibney R, Lager DJ. Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine. Am. J. Kidney Dis. 36,1034–1040 (2000).
   Google Scholar
• Echaniz-Laguna A, Thiriaux A, Ruolt-Olivesi I, Marescaux C, Hirsch E. Lupus anticoagulant induced by the combination of valproate and lamotrigine. Epilepsia 40, 1661–1663 (1999).
   PubMed Web of Science ®Google Scholar
• Pulik M, Lionnet F, Genet P Successful treatment of lamotrigine-induced erythroblastopenic crisis with folinic acid. Neurol. 55,1235–1236 (2000).
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Panni B, Cazzola M, Muzzupappa S, Turiel M. Lamotrigine-induced lupus. Lupus 9,555–557 (2000).
   Google Scholar
• Sotero de Menezes MA, Rho JM, Murphy P, Cheyette S. Lamotrigine-induced tic disorder: report of five pediatric cases. Epilepsia 41,862–867 (2000).
   PubMed Web of Science ®Google Scholar
• Lombroso CT. Lamotrigine-induced tourettism. Neurol 52,1191–1194 (1999).
   PubMed Web of Science ®Google Scholar